Showing results (41-50 of 106) with videos related to
Sort By:
Pageof 11
Blood|February 12, 2016
Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutationMaria I Mascarenhas, Wendi A Bacon, Chrysa Kapeni, et al.Radiation Oncology (London, England)|August 11, 2011
Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremitiesKelly K Curtis, Jonathan B Ashman, Christopher P Beauchamp, et al.Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.Journal of Clinical Microbiology|August 6, 2005
Genetic diversity of Campylobacter sp. isolates from retail chicken products and humans with gastroenteritis in Central MichiganBrooke R Fitch, Kacey L Sachen, Stacey R Wilder, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 8, 2006
Phase II trial of oral vinorelbine for the treatment of metastatic breast cancer in patients > or = 65 years of age: an NCCTG studyM Baweja, V J Suman, T R Fitch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2005
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II studyS R Alberts, N R Foster, R F Morton, et al.Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Oral vinorelbine for the treatment of metastatic non-small cell lung cancer in elderly patients: a phase II trial of efficacy and toxicityAnne Kanard, Aminah Jatoi, Rene Castillo, et al.The Lancet. Oncology|October 4, 2005
5-Hydroxytryptamine-receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trialJane T Hickok, Joseph A Roscoe, Gary R Morrow, et al.The Medical Journal of Australia|January 4, 1988
Preliminary experience with a combined-modality approach to the management of oesophageal cancerJ W Denham, P G Gill, G G Jamieson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2008
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336Alvaro Moreno-Aspitia, Roscoe F Morton, David W Hillman, et al.Pageof 11